Montana Molecular News
Light Activated Lipids
Activating a signaling pathway with light is one of the brightest ideas to come along. Pietro de Camilli's and Bertil Hille's labs collaborated on a brilliant example of this illuminating technique! Optogenetic control of phosphoinositide metabolism describes...
Montana Molecular publishes new diacylglycerol sensor
Despite the importance to our health, the biology of how drugs work at the cellular level, remains largely a mystery. In a recent Public Library of Science (PLoS One) article, Montana Molecular describes new diacylglycerol sensors to help...
Dimerization Dependent Red Fluorescent Protein
Imagine the possibilities! In an impressive feat of rational engineering and directed evolution, Spencer C. Alford et.al. from Bob Campbell's lab at the University of Alberta developed ddRFP, a dimerization dependent bright new red that can be used to image...
Montana matches SBIR to build diacylglycerol assay
There are advantages to starting up a biotech company in Montana. For instance, companies like Montana Molecular that receive federal SBIR Phase 1 grants are eligible for state matching funds and can be used to help cover patent applications,...
Making the most of two photons
Excellent 3D resolution and minimal photobleaching made possible by multi photon microscopy are important advantages for fluorescence imaging in living cells. Until Misha Drobizhev et.al. tackled the issue, surprisingly little was known about the two photon absorption...
Montana Molecular awarded SBIR from National Institutes of Health
Montana Molecular Awarded 350K SBIR Phase 1 from NIH to develop fluorescent assays for cell-based drug discovery. BOZEMAN, MT. Montana Molecular was awarded an SBIR grant from the National Institute of Mental Health to develop fluorescent tools for...
Multicolored Calcium Imaging
Looking for inspiration? Check out Yongzin Zhao's et.al's elegant paper on how the Campbell lab expanded the palette of genetically encoded calcium sensors that modulate fluorescence in response to changes in calcium. An Expanded Palette of Genetically Encoded Ca2+...
Montana Molecular selected for MBRCT Award
Montana Molecular's breakthroughs in cell based assay technologies have been made possible in part by continued support from the Montana Board of Research and Commercialization. The proposal entitled, "An Integrated Platform for Cell-Based Drug...
Billings Gazette, January 25, 2009
Firm Seeks Tools to Aid in Finding Cures, Billings Gazette, January 25, 2009
Bozeman Daily Chronicle, May 23, 2008
Bozeman Firm Receives $210K Federal Grant, Bozeman Daily Chronicle, May 23, 2008 Bozeman-based Montana Molecular Inc. has received a $210,092 federal grant to continue it's clinical research related to neurological functions and disorders, and...
